Brief: Marinus Pharmaceuticals Says On August 17, The PTAB Granted Co's Petition Seeking Post-Grant Review Of Ovid Therapeutics'
21/08/2023 12:16
Aug 21 (Reuters) - Marinus Pharmaceuticals Inc MRNS.O :
* MARINUS PHARMACEUTICALS INC - ON AUGUST 17, THE PTAB
GRANTED
CO'S PETITION SEEKING POST-GRANT REVIEW OF OVID THERAPEUTICS'
U.S. PATENT NO. 11,395,817
Further company coverage: MRNS.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Marinus Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP- Axsome Therapeutics, Ducommun, Vacasa
Brief: Immedica To Acquire Biopharmaceutical Company Marinus Pharmaceuticals
Marinus Pharmaceuticals Inc expected to post a loss of 41 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Appfolio, S&P Global, Uber
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group